U.S. Software Stock News

NYSE:FUL
NYSE:FULChemicals

Assessing H.B. Fuller (FUL) Valuation As Shares Trade Below Narrative Fair Value

How H.B. Fuller Stock Has Been Trading Recently H.B. Fuller (FUL) has seen relatively muted share performance lately, with the stock around $59.95 and negative returns over the past week, month, and past 3 months, despite a positive 1 year total return. For context, the company carries a market value of about $3.27b and generates annual revenue of roughly $3.46b with net income of about $159.76m. This reflects its role as an established adhesives and specialty chemicals supplier. See our...
NYSE:OMF
NYSE:OMFConsumer Finance

Is Receivables Expansion in Auto and Cards Reshaping OneMain Holdings’ (OMF) Investment Case?

In the first quarter of 2026, OneMain Holdings reported net income of US$226 million, up from US$213 million a year earlier, and affirmed a quarterly dividend of US$1.05 per share payable on May 15, 2026. Beyond headline earnings, growth in auto finance and credit card receivables, supported by cost-saving AI tools and disciplined underwriting, underscored management’s push to broaden revenue sources while maintaining credit stability. Next, we’ll examine how this receivables growth in newer...
NYSE:LXU
NYSE:LXUChemicals

Earnings Turnaround and Carbon Capture Progress Could Be A Game Changer For LSB Industries (LXU)

In the past quarter, LSB Industries, Inc. reported first‑quarter 2026 sales of US$169.49 million, up from US$143.43 million a year earlier, and moved from a net loss to net income of US$19.69 million, with basic and diluted earnings per share from continuing operations at US$0.27. Beyond the headline turnaround, the results were supported by tight nitrogen fertilizer markets, improved production performance, and progress on LSB’s El Dorado carbon capture and sequestration project, alongside...
NYSE:SHAK
NYSE:SHAKHospitality

The Bull Case For Shake Shack (SHAK) Could Change Following Analyst Optimism And Vanguard’s 5% Stake - Learn Why

In late April and early May 2026, analysts became more positive on Shake Shack’s upcoming May 7 earnings report, expecting lower year-on-year earnings but higher revenue and highlighting a positive Earnings ESP alongside a track record of beating EPS estimates in recent quarters. At the same time, Vanguard disclosed passive beneficial ownership stakes of just over 5% in Shake Shack, underscoring growing institutional interest even as earnings expectations remain mixed. Next, we’ll examine...
NYSE:DVA
NYSE:DVAHealthcare

Is It Time To Reassess DaVita (DVA) After Its Strong Year To Date Rally

If you are wondering whether DaVita at around US$151.65 is still priced reasonably or already baking in a lot of optimism, the next sections will help you frame that question clearly. The stock's recent performance has been mixed in the short term, with a 0.1% decline over 7 days, a 4.2% gain over 30 days, and longer term returns of 32.4% year to date, 7.5% over 1 year, 71.4% over 3 years, and 19.6% over 5 years. Recent coverage has focused on DaVita's role in the US healthcare system and...
NasdaqGS:LOPE
NasdaqGS:LOPEConsumer Services

A Look At Grand Canyon Education (LOPE) Valuation After Recent Share Price Weakness

Recent share performance and business snapshot Grand Canyon Education (LOPE) has seen its share price under pressure recently, with a 3.3% decline over the past day, a 4.6% drop over the past month, and a 6.7% fall in the past 3 months. Over a longer horizon, the stock shows a 1.2% decline year to date and a 12.3% total return decline over the past year, set against a 45.8% total return gain across 3 years and 72.9% over 5 years. See our latest analysis for Grand Canyon Education. The recent...
NasdaqGM:KOD
NasdaqGM:KODBiotechs

Assessing Kodiak Sciences (KOD) Valuation After New KSI-101 Retinal Trial Updates

Kodiak Sciences (KOD) is back in focus after sharing new KSI-101 clinical data in Asian MESI patients at the AUS and ARVO meetings, reinforcing interest in its expanding retinal disease pipeline. See our latest analysis for Kodiak Sciences. The clinical updates around KSI-101 arrive after a sharp re-rating in Kodiak Sciences, with the share price at US$43.96 and a 90-day share price return of 82.33%, contributing to a very large 1-year total shareholder return, while the 5-year total...
NYSE:BOX
NYSE:BOXSoftware

Will Box Automate’s AI Workflows Make Content Box's (BOX) True Operating System?

On 28 April 2026, Box, Inc. launched Box Automate, a no-code, AI-driven workflow automation solution built natively on its content platform to orchestrate work across people, AI agents, and enterprise systems. The release positions Box to embed AI deeper into everyday document-centric processes across HR, finance, legal, and public sector workflows, potentially making content the operational backbone rather than a passive repository. We’ll now assess how Box Automate’s AI-powered, no-code...
NasdaqGS:PEGA
NasdaqGS:PEGASoftware

A Look At Pegasystems (PEGA) Valuation After Blueprint AI Momentum And Mixed Q1 Results

Pegasystems (PEGA) is back in focus after first quarter earnings showed revenue of US$429.97 million and net income of US$32.76 million, alongside growing attention on its AI native Blueprint platform and customer engagement trends. See our latest analysis for Pegasystems. The first quarter update and growing attention on the Blueprint platform come against a tougher trading backdrop, with a 30 day share price return showing a 15.06% decline and year to date share price return showing a...
NYSE:HUBS
NYSE:HUBSSoftware

A Look At HubSpot (HUBS) Valuation As AI Momentum And SaaS Sector Optimism Lift Sentiment

HubSpot (HUBS) has been back in focus after a sector wide lift in software as a service names, as well as growing attention on its AI products, customer growth, and upcoming earnings report. See our latest analysis for HubSpot. The recent 8.2% one day share price gain sits against a weaker backdrop, with a year to date share price return of 37.24% decline and a 1 year total shareholder return of 62.27% decline. This suggests short term momentum has picked up while longer term performance...
NYSE:HCA
NYSE:HCAHealthcare

HCA Expands Florida Footprint And Refines Messaging With New Leadership

HCA Healthcare (NYSE:HCA) is opening a new full-service hospital in Gainesville, the first new facility of its kind in the area in more than 50 years. The company is planning a substantial expansion at Kendall Hospital in Miami-Dade, aimed at increasing capacity and service reach in South Florida. Cynthia Cifuentes-Finkel has been appointed senior vice president of marketing and corporate affairs, with responsibility for brand leadership and stakeholder engagement. For investors watching...
NasdaqGS:ALGN
NasdaqGS:ALGNMedical Equipment

Align Technology (ALGN) Is Down 5.6% After Earnings Beat And New Buyback - Has The Bull Case Changed?

In late April 2026, Align Technology reported first-quarter sales of US$1,040.09 million and net income of US$112.77 million, beating analyst expectations while reaffirming its full-year 2026 guidance and announcing an additional US$200 million share repurchase under its existing US$1 billion program. At the same time, Align used the AAO 2026 conference to showcase advances across its digital orthodontic platform, including 3D printed attachment systems, enhanced palatal expanders, and...
NasdaqGM:CRSP
NasdaqGM:CRSPBiotechs

Assessing CRISPR Therapeutics (CRSP) Valuation After Casgevy Approval And CAR T Pipeline Progress

Regulatory approval shifts focus to CRISPR Therapeutics stock CRISPR Therapeutics (CRSP) has moved into the spotlight after securing regulatory approval for its first gene editing therapy, Casgevy, for blood disorders, along with progress in its CAR T pipeline. See our latest analysis for CRISPR Therapeutics. At a share price of US$51.63, CRISPR Therapeutics has seen short term momentum pick up, with a 7 day share price return of 5.83%, while the 1 year total shareholder return of 34.98%...
NasdaqGS:META
NasdaqGS:METAInteractive Media and Services

Meta Trading AI Spending For Jobs And Testing Long‑Term Returns

Meta Platforms announced major layoffs directly tied to a surge in AI infrastructure spending. CEO Mark Zuckerberg framed the headcount reductions as a trade-off to fund record AI investments. The company signaled that further workforce cuts are possible later this year if AI priorities require it. Meta Platforms (NasdaqGS: META) is making these cuts while its shares trade around $608.75. The stock has a mixed recent profile, with a 6.0% gain over the past month alongside a 9.8% decline...
NYSE:CTS
NYSE:CTSElectronic

What CTS (CTS)'s Strong Q1 Results and Narrowed 2026 Outlook Range Mean For Shareholders

In the first quarter of 2026, CTS Corporation reported higher sales of US$139.23 million and net income of US$17.20 million year over year, and narrowed its full‑year 2026 sales guidance range to US$560 million–US$580 million. Management also reiterated plans to pursue acquisitions to diversify and improve the quality of earnings, signaling continued use of the company’s balance sheet for growth and shareholder returns. Next, we’ll examine how CTS’s stronger quarterly earnings and...
NasdaqGS:DUOL
NasdaqGS:DUOLConsumer Services

Duolingo (DUOL) Is Up 7.5% After Analysts Highlight Another Potential Earnings Beat - What's Changed

In recent days, analysts have highlighted Duolingo, Inc. as having a positive earnings outlook, a history of outperforming estimates, and expectations for quarterly earnings of US$0.79 per share alongside revenue growth of 25.1% year over year. This renewed optimism centers on Duolingo’s ability to convert strong user engagement into higher subscription revenues, supported by consistent earnings surprises that have reinforced confidence in its business model. We’ll now examine how this...
NYSE:MNR
NYSE:MNROil and Gas

Mach Natural Resources (MNR) Is Up 5.7% After Conflicting Q1 EPS Signals Has The Bull Case Changed?

Mach Natural Resources LP is set to report its Q1 2026 earnings on May 7, with analysts expecting lower year-over-year earnings despite higher revenue and a recent sharp upward revision to consensus EPS estimates. This mix of declining earnings expectations, upgraded forecasts, and an Earnings ESP of 0% has heightened uncertainty around the results and management’s commentary, which could be influential for investors following the story. We’ll now examine how this upcoming earnings report,...
NYSE:FCX
NYSE:FCXMetals and Mining

Reassessing Freeport-McMoRan (FCX) Valuation After Morgan Stanley Downgrade And Grasberg Cost Concerns

Morgan Stanley’s downgrade of Freeport-McMoRan (FCX) to Equal Weight, tied to expectations of a slower Grasberg Block Cave ramp-up and higher costs in Indonesia, has become a key pressure point for the stock. See our latest analysis for Freeport-McMoRan. Recent trading has turned weaker, with a 1 day share price return showing a 2.13% decline and a 30 day share price return showing a 7.87% decline. However, the 1 year total shareholder return of 52.15% still signals stronger longer term...
NYSE:ATEN
NYSE:ATENSoftware

Is It Too Late To Consider A10 Networks (ATEN) After Its Strong Multi‑Year Rally?

If you are wondering whether A10 Networks at around US$26.85 is priced attractively or already baking in a lot of optimism, this breakdown is designed to help you frame that question clearly. The stock has seen a 2.6% decline over the last 7 days, alongside returns of 11.9% over 30 days, 54.8% year to date, 65.9% over 1 year, 104.3% over 3 years and 214.4% over 5 years. These movements can change how the market views both its potential and its risks. Recent coverage has focused on A10...
NasdaqGS:CHYM
NasdaqGS:CHYMDiversified Financial

Chime Financial Taps Classroom AI Partnership To Shape Long Term Brand Story

Chime Financial (NasdaqGS:CHYM) has partnered with Junior Achievement USA to roll out AI powered financial literacy programs for students. The partnership includes a redesign of the JA Finance Park program to introduce interactive, experiential money management and career readiness modules. The initiative launches during Financial Literacy Month and focuses on preparing young people for real world financial decisions. For investors tracking Chime Financial, the partnership arrives as the...
NasdaqGM:RZLV
NasdaqGM:RZLVSoftware

Rezolve AI Revolut Listing Expands SQD Reach While Valuation Questions Linger

Rezolve AI's SQD token has been listed on Revolut, expanding access to more than 70 million users worldwide. The listing brings SQD onto a large mainstream fintech platform, beyond crypto focused exchanges. This move is positioned as a step toward mass market adoption of Rezolve AI's decentralized AI commerce infrastructure. Rezolve AI, listed as NasdaqGM:RZLV, is building a decentralized AI commerce infrastructure designed to connect agentic AI systems with real world transactional data...
NasdaqCM:QUBT
NasdaqCM:QUBTTech

Assessing Quantum Computing Inc. (QUBT) Valuation After NeuraWave Deployment Readiness And Conference Spotlight

Quantum Computing (QUBT) is back in focus after confirming that NeuraWave, its photonic reservoir computing platform, is deployment-ready. Management is also preparing to showcase the technology at the upcoming Needham Technology, Media & Consumer Conference. See our latest analysis for Quantum Computing. The NeuraWave update arrives after a sharp 34.06% 1 month share price return, even as the year to date share price return is a 16.35% decline and the 3 year total shareholder return is...
NasdaqGS:AMGN
NasdaqGS:AMGNBiotechs

Did Amgen’s Raised 2026 Outlook and AI-Focused Overhaul Just Shift AMGN’s Investment Narrative?

In the past week, Amgen reported first-quarter 2026 results showing revenue of US$8,618 million and net income of US$1,819 million, with both basic and diluted earnings per share from continuing operations rising year on year, and confirmed it has completed a long-running share repurchase program totaling about US$60.59 billion. Management also raised full-year 2026 revenue guidance and highlighted strong volume growth across key drugs and advancing late-stage candidates, while announcing...
NYSE:SE
NYSE:SEMultiline Retail

Sea (NYSE:SE) Valuation Check As Growth Hopes And Monee Expansion Lift Investor Optimism

Sea (NYSE:SE) is back in focus after recent coverage highlighted expectations for strong earnings and revenue growth ahead of its May 12 report, with fintech arm Monee emerging as a key operational driver. See our latest analysis for Sea. Sea’s recent 1 day share price return of 1.56% and 1 month share price return of 4.76% sit against a weaker backdrop, with a 90 day share price return of a 24.11% decline and a 1 year total shareholder return of a 39.2% decline. This suggests recent momentum...